000 01536 a2200433 4500
005 20250517232854.0
264 0 _c20190422
008 201904s 0 0 eng d
022 _a1097-0215
024 7 _a10.1002/ijc.31798
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPedersen, Martin H
245 0 0 _aCYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
_h[electronic resource]
260 _bInternational journal of cancer
_c02 2019
300 _a631-640 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBiomarkers, Tumor
_xbiosynthesis
650 0 4 _aCohort Studies
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aGene Expression
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aLymph Nodes
_xpathology
650 0 4 _aLymphatic Metastasis
650 0 4 _aMiddle Aged
650 0 4 _aNADPH-Ferrihemoprotein Reductase
_xbiosynthesis
650 0 4 _aNeoplasm Recurrence, Local
_xenzymology
650 0 4 _aTriple Negative Breast Neoplasms
_xenzymology
700 1 _aHood, Brian L
700 1 _aEhmsen, Sidse
700 1 _aBeck, Hans C
700 1 _aConrads, Thomas P
700 1 _aBak, Martin
700 1 _aDitzel, Henrik J
700 1 _aLeth-Larsen, Rikke
773 0 _tInternational journal of cancer
_gvol. 144
_gno. 3
_gp. 631-640
856 4 0 _uhttps://doi.org/10.1002/ijc.31798
_zAvailable from publisher's website
999 _c28732301
_d28732301